Longitudinal examination of peripheral blood from stage IV melanoma patients identified PD-1+ CD8 T-cells as the main targets of PD-1 inhibition, which causes a marked expansion of an IFN-γ-producing CXCR5+PD-1+ subset [74]. This evidence concerns the gene PDCD1 and melanoma.